159 related articles for article (PubMed ID: 27127883)
1. Similar cisplatin sensitivity of HPV-positive and -negative HNSCC cell lines.
Busch CJ; Becker B; Kriegs M; Gatzemeier F; Krüger K; Möckelmann N; Fritz G; Petersen C; Knecht R; Rothkamm K; Rieckmann T
Oncotarget; 2016 Jun; 7(24):35832-35842. PubMed ID: 27127883
[TBL] [Abstract][Full Text] [Related]
2. Effect of sorafenib on cisplatin-based chemoradiation in head and neck cancer cells.
Möckelmann N; Rieckmann T; Busch CJ; Becker B; Gleißner L; Hoffer K; Omniczynski M; Steinmeister L; Laban S; Grénman R; Petersen C; Rothkamm K; Dikomey E; Knecht R; Kriegs M
Oncotarget; 2016 Apr; 7(17):23542-51. PubMed ID: 27015558
[TBL] [Abstract][Full Text] [Related]
3. Treatment response of HPV-positive and HPV-negative head and neck squamous cell carcinoma cell lines.
Nagel R; Martens-de Kemp SR; Buijze M; Jacobs G; Braakhuis BJ; Brakenhoff RH
Oral Oncol; 2013 Jun; 49(6):560-6. PubMed ID: 23578372
[TBL] [Abstract][Full Text] [Related]
4. Wee-1 Kinase Inhibition Sensitizes High-Risk HPV+ HNSCC to Apoptosis Accompanied by Downregulation of MCl-1 and XIAP Antiapoptotic Proteins.
Tanaka N; Patel AA; Wang J; Frederick MJ; Kalu NN; Zhao M; Fitzgerald AL; Xie TX; Silver NL; Caulin C; Zhou G; Skinner HD; Johnson FM; Myers JN; Osman AA
Clin Cancer Res; 2015 Nov; 21(21):4831-44. PubMed ID: 26124202
[TBL] [Abstract][Full Text] [Related]
5. Effect of radiation on cell proliferation and tumor hypoxia in HPV-positive head and neck cancer in vivo models.
Sørensen BS; Busk M; Horsman MR; Alsner J; Overgaard J; Kyle AH; Minchinton AI
Anticancer Res; 2014 Nov; 34(11):6297-304. PubMed ID: 25368228
[TBL] [Abstract][Full Text] [Related]
6. HPV-positive HNSCC cell lines but not primary human fibroblasts are radiosensitized by the inhibition of Chk1.
Busch CJ; Kriegs M; Laban S; Tribius S; Knecht R; Petersen C; Dikomey E; Rieckmann T
Radiother Oncol; 2013 Sep; 108(3):495-9. PubMed ID: 23932155
[TBL] [Abstract][Full Text] [Related]
7. HNSCC cell lines positive for HPV and p16 possess higher cellular radiosensitivity due to an impaired DSB repair capacity.
Rieckmann T; Tribius S; Grob TJ; Meyer F; Busch CJ; Petersen C; Dikomey E; Kriegs M
Radiother Oncol; 2013 May; 107(2):242-6. PubMed ID: 23602369
[TBL] [Abstract][Full Text] [Related]
8. Heat shock protein 90 (HSP90) is overexpressed in p16-negative oropharyngeal squamous cell carcinoma, and its inhibition in vitro potentiates the effects of chemoradiation.
Patel K; Wen J; Magliocca K; Muller S; Liu Y; Chen ZG; Saba N; Diaz R
Cancer Chemother Pharmacol; 2014 Nov; 74(5):1015-22. PubMed ID: 25205430
[TBL] [Abstract][Full Text] [Related]
9. The inhibition of PARP but not EGFR results in the radiosensitization of HPV/p16-positive HNSCC cell lines.
Güster JD; Weissleder SV; Busch CJ; Kriegs M; Petersen C; Knecht R; Dikomey E; Rieckmann T
Radiother Oncol; 2014 Dec; 113(3):345-51. PubMed ID: 25467050
[TBL] [Abstract][Full Text] [Related]
10. STI-571 (Gleevec) potentiates the effect of cisplatin in inhibiting the proliferation of head and neck squamous cell carcinoma in vitro.
Wang-Rodriguez J; Lopez JP; Altuna X; Chu TS; Weisman RA; Ongkeko WM
Laryngoscope; 2006 Aug; 116(8):1409-16. PubMed ID: 16885745
[TBL] [Abstract][Full Text] [Related]
11. Human papillomavirus associated XPF deficiency increases alternative end joining and cisplatin sensitivity in head and neck squamous cell carcinoma.
Zuo N; Ma L; Liu T; Hu W; Luo Y; Meng H; Ren Q; Deng Y; Wei L; Liu Q
Oral Oncol; 2023 May; 140():106367. PubMed ID: 36996606
[TBL] [Abstract][Full Text] [Related]
12. Dose-Modifying Factor of Radiation Therapy with Concurrent Cisplatin Treatment in HPV-Positive Squamous Cell Carcinoma: A Preclinical Study.
Prevc A; Kranjc S; Cemazar M; Todorovic V; Zegura B; Novak M; Filipic M; Flezar MS; Kirbis IS; Rotter A; Brozic A; Zakelj MN; Poljak M; Hosnjak L; Groselj B; Strojan P; Sersa G
Radiat Res; 2018 Jun; 189(6):644-651. PubMed ID: 29652621
[TBL] [Abstract][Full Text] [Related]
13. Immune response during therapy with cisplatin or radiation for human papillomavirus-related head and neck cancer.
Spanos WC; Nowicki P; Lee DW; Hoover A; Hostager B; Gupta A; Anderson ME; Lee JH
Arch Otolaryngol Head Neck Surg; 2009 Nov; 135(11):1137-46. PubMed ID: 19917928
[TBL] [Abstract][Full Text] [Related]
14. A 13-gene expression-based radioresistance score highlights the heterogeneity in the response to radiation therapy across HPV-negative HNSCC molecular subtypes.
Foy JP; Bazire L; Ortiz-Cuaran S; Deneuve S; Kielbassa J; Thomas E; Viari A; Puisieux A; Goudot P; Bertolus C; Foray N; Kirova Y; Verrelle P; Saintigny P
BMC Med; 2017 Sep; 15(1):165. PubMed ID: 28859688
[TBL] [Abstract][Full Text] [Related]
15. Radiation-Induced Dedifferentiation of Head and Neck Cancer Cells Into Cancer Stem Cells Depends on Human Papillomavirus Status.
Vlashi E; Chen AM; Boyrie S; Yu G; Nguyen A; Brower PA; Hess CB; Pajonk F
Int J Radiat Oncol Biol Phys; 2016 Apr; 94(5):1198-206. PubMed ID: 27026319
[TBL] [Abstract][Full Text] [Related]
16. TMEM16A/ANO1 is differentially expressed in HPV-negative versus HPV-positive head and neck squamous cell carcinoma through promoter methylation.
Dixit R; Kemp C; Kulich S; Seethala R; Chiosea S; Ling S; Ha PK; Duvvuri U
Sci Rep; 2015 Nov; 5():16657. PubMed ID: 26563938
[TBL] [Abstract][Full Text] [Related]
17. ATR inhibition sensitizes HPV
Leonard BC; Lee ED; Bhola NE; Li H; Sogaard KK; Bakkenist CJ; Grandis JR; Johnson DE
Oral Oncol; 2019 Aug; 95():35-42. PubMed ID: 31345392
[TBL] [Abstract][Full Text] [Related]
18. Chemotherapeutic alteration of VEGF-/PDGF- and PDGF-Rα/β expression by imatinib in HPV-transformed squamous cell carcinoma compared to HPV-negative HNSCC in vitro.
Schultz JD; Mühlheim K; Erben P; Hofheinz RD; Faber A; Thorn C; Sommer JU; Hörmann K; Sauter A
Oncol Rep; 2011 Nov; 26(5):1099-109. PubMed ID: 21805039
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant chemoradiation therapy with high-dose versus weekly cisplatin for resected, locally-advanced HPV/p16-positive and negative head and neck squamous cell carcinoma.
Geiger JL; Lazim AF; Walsh FJ; Foote RL; Moore EJ; Okuno SH; Olsen KD; Kasperbauer JL; Price DL; Garces YI; Ma DJ; Neben-Wittich MA; Molina JR; Garcia JJ; Price KA
Oral Oncol; 2014 Apr; 50(4):311-8. PubMed ID: 24467937
[TBL] [Abstract][Full Text] [Related]
20. The chemopreventive and clinically used agent curcumin sensitizes HPV (-) but not HPV (+) HNSCC to ionizing radiation, in vitro and in a mouse orthotopic model.
Tuttle S; Hertan L; Daurio N; Porter S; Kaushick C; Li D; Myamoto S; Lin A; O'Malley BW; Koumenis C
Cancer Biol Ther; 2012 May; 13(7):575-84. PubMed ID: 22441776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
